Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
children save search
The Children’s Place Announces $90 Million in New Unsecured Financing Provided by Majority Shareholder Mithaq Capital
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
PLCE | $8.37 1.09% 1.08% 1.9M
|
Retail Trade
|
| O: 30.5%
H: 21.66%
C: -11.63%
million
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of The Children's Place
Published: 2024-04-13 (Crawled : 12:20) - prnewswire.com
INOD | $5.87 -0.68% -0.68% 220K
|
Technology Services
| Email alert
Add to watchlist
PLCE | $8.37 1.09% 1.08% 1.9M
|
Retail Trade
| Email alert
Add to watchlist
deadline
SchoolsFirst FCU Celebrates 2023 Year of Giving to Children's Miracle Network Hospitals
Published: 2024-04-12 (Crawled : 22:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
| Email alert
Add to watchlist
year network
AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: 0.0%
label children astrazeneca
AstraZeneca Expands Fasenra’s Label to Children Aged 6 to 11 with Severe Asthma
Published: 2024-04-12 (Crawled : 12:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: 0.0%
label children astrazeneca
FASENRA approved for treatment of children aged 6 to 11 with severe asthma
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 1.47%
H: 1.16%
C: -1.27%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 3.34%
H: 0.27%
C: -0.62%
children approved treatment for
Contact Levi & Korsinsky by April 29, 2024 Deadline to Join Class Action Against The Children's Place, Inc.(PLCE)
Published: 2024-04-08 (Crawled : 10:00) - prnewswire.com
PLCE | $8.37 1.09% 1.08% 1.9M
|
Retail Trade
|
| O: -6.19%
H: 0.0%
C: 0.0%
deadline
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages The Children's Place, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PLCE
Published: 2024-04-07 (Crawled : 12:20) - prnewswire.com
INOD | $5.87 -0.68% -0.68% 220K
|
Technology Services
| Email alert
Add to watchlist
IRTC | News | $112.18 0.62% 0.62% 260K
|
Health Technology
| Email alert
Add to watchlist
PLCE | $8.37 1.09% 1.08% 1.9M
|
Retail Trade
| Email alert
Add to watchlist
deadline
Herbalife Family Foundation Celebrates 30 Years of Giving Back to Children and Families Around the World, Donating More than $50 Million Since 2005
Published: 2024-04-05 (Crawled : 16:00) - prnewswire.com
HLF | $8.59 4.37% -2.1% 1.2M
|
Distribution Services
|
| O: -0.52%
H: 4.27%
C: 3.29%
children back million family foundation
PLCE Investors Have Opportunity to Lead The Children's Place, Inc. Securities Fraud Lawsuit
Published: 2024-04-04 (Crawled : 22:00) - prnewswire.com
PLCE | $8.37 1.09% 1.08% 1.9M
|
Retail Trade
|
| O: -3.85%
H: 0.0%
C: 0.0%
AVXL | $3.8 -6.63% -7.11% 1.7M
|
Health Technology
|
| O: -0.67%
H: 1.46%
C: -0.67%
Ford's Garage Partners with First Responders Children's Foundation to Support Families of Community Heroes
Published: 2024-04-04 (Crawled : 16:00) - prnewswire.com
F | $12.06 0.17% 0.08% 40M
|
Consumer Durables
|
| O: 1.83%
H: 0.0%
C: 0.0%
first foundation
OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)
Published: 2024-04-04 (Crawled : 12:00) - globenewswire.com
KIDS | $29.485 -1.39% -1.41% 81K
|
Health Technology
|
| O: 5.72%
H: 0.43%
C: -3.65%
symposium spine international solutions
Taro Pharmaceuticals U.S.A., Inc. Expands OTC Portfolio for Children with the Introduction of bébé Bottoms™ Diaper Rash Crème Spray
Published: 2024-03-28 (Crawled : 18:00) - prnewswire.com
TARO | $42.19 -0.12% 0.0% 31K
|
Health Technology
| Email alert
Add to watchlist
children pharmaceuticals spray
PLCE Investors Have Opportunity to Lead The Children's Place, Inc. Securities Fraud Lawsuit
Published: 2024-03-28 (Crawled : 17:00) - prnewswire.com
LUXH | $0.901 -15.79% -18.76% 430K
|
|
| O: 1.33%
H: 0.66%
C: -9.21%
IRTC | News | $112.18 0.62% 0.62% 260K
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
PLCE | $8.37 1.09% 1.08% 1.9M
|
Retail Trade
|
| O: -1.13%
H: 2.85%
C: -5.87%
New Report Reveals Demand for Youth Banking is High Among Families with Generation Z and Alpha Children
Published: 2024-03-28 (Crawled : 13:00) - globenewswire.com
RPMT | $1.08 17.09% 5.1K
|
Information
|
| O: 0.94%
H: 0.0%
C: -1.4%
QTWO | $49.81 -0.56% 0.0% 350K
|
Technology Services
|
| O: 0.02%
H: 1.53%
C: 0.1%
report children
Blüm Responds to Allegations of Child Molestation By Bernard Steimann, “People’s California” Managing Member; Denounces Sexual Abuse of Children
Published: 2024-03-28 (Crawled : 13:00) - globenewswire.com
MDRR | $5.6 2.33% 820
|
Finance
|
| O: 0.0%
H: 0.0%
C: -0.35%
children
United States Food & Drug Administration Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease
Published: 2024-03-26 (Crawled : 07:00) - biospace.com/
MESO | $5.14 2.6% 2.53% 270K
|
Health Technology
|
| O: 23.18%
H: 0.0%
C: 0.0%
drug disease children food trial submission
United States Food & Drug Administration (FDA) Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)
Published: 2024-03-26 (Crawled : 03:00) - globenewswire.com
MESO | $5.14 2.6% 2.53% 270K
|
Health Technology
|
| O: 23.18%
H: 0.0%
C: 0.0%
drug disease children food trial submission
SERIOUSFUN CHILDREN'S NETWORK NAMES JOHN FRASCOTTI AS NEW BOARD CHAIR AND MAURICE PRATT AS VICE CHAIR FOLLOWING FIVE YEARS BOARD CHAIR
Published: 2024-03-25 (Crawled : 13:00) - prnewswire.com
HAS | $54.93 0.2% 0.2% 1.4M
|
Consumer Durables
|
| O: -0.57%
H: 2.7%
C: 2.55%
network pratt
Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy
Published: 2024-03-20 (Crawled : 11:00) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
children approved therapeutics therapy
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.